GlassScriptPhysician profile
Coridon Michael Huez
NPI 1235421553
$790.07
in general payments reported to CMS, 2019-2025
12 companies · $40.68 in 2025
The $40.68 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $332 · 2020: $15.77 · 2022: $27.21 · 2023: $215 · 2024: $160 · 2025: $40.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $231 · Food and Beverage: $165 · Consulting Fee: $19.28.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $230.79 |
| Food and Beverage | $165.41 |
| Consulting Fee | $19.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $241.21 | 2023-2024 | Comprehensive Shoulder System, Persona, Gel-One Cross-Linked Hyaluronate |
| Smith+Nephew, INC. | $179.44 | 2019-2023 | Pico |
| Medtronic USA, INC. | $177.68 | 2019 | |
| Next Science LLC | $38.56 | 2024 | Surgx, Blastx, Xperience |
| Depuy Synthes Sales INC. | $34.15 | 2020-2025 | Motoband |
| Heron Therapeutics, INC. | $22.30 | 2025 | Zynrelef |
| Csl Behring | $20.69 | 2019 | |
| Kerecis Limited | $18.51 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Organogenesis INC. | $17.09 | 2023 | Puraply |
| Radius Health, INC. | $13.77 | 2022 | |
| Merck Sharp & Dohme LLC | $13.44 | 2022 | |
| Amgen INC. | $13.23 | 2024 | Evenity, Prolia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Coridon Huez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.